![Charles Hewitt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Charles Hewitt
Investitore di Private Equity presso
Epic BioVentures LLC
Profilo
Charles W.
Hewitt is the founder of BioFX Laboratories, Inc. He is currently the Managing Partner at Epic BioVentures LLC.
Previously, he worked as the Chief Scientific Officer at EPIX Pharmaceuticals, Inc. Hewitt received his undergraduate degree from the University of California, Riverside in 1976, his graduate degree from California State Polytechnic University (Pomona) in 1980, and his doctorate from the University of South Carolina in 1987.
Posizioni attive di Charles Hewitt
| Società | Posizione | Inizio |
|---|---|---|
Epic BioVentures LLC
 Epic BioVentures LLC Investment ManagersFinance Epic BioVentures focuses on investments in early- to mid-stage medical device, biotechnology, diagnostic and pharmaceutical companies. The firm targets companies with: (1) modest capital requirements (2) a preferred exit strategy by acquisition or merger with a corporate partner and (3) exit timing of 3 three years, often prior to pivotal clinical trials or market launch. The Epic BioVentures I Fund invests in early to mid-stage medical technology companies with high anticipated return potential. Epic BioVentures mitigates risk through investments in a well-diversified portfolio. They seek to invest in portfolio companies with the strong potential to exit within 3 years of their investment | Investitore di Private Equity | 01/08/2010 |
Precedenti posizioni note di Charles Hewitt
| Società | Posizione | Fine |
|---|---|---|
EPIX Pharmaceuticals, Inc.
 EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Develops pharmaceuticals | Corporate Officer/Principal | - |
BioFX Laboratories, Inc.
 BioFX Laboratories, Inc. BiotechnologyHealth Technology Develops and supplies reagents for the biomedical research market | Fondatore | - |
Formazione di Charles Hewitt
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
93
Relazioni di 1° grado
6
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
EPIX Pharmaceuticals, Inc.
EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Develops pharmaceuticals | Health Technology |
University of California, Riverside
 University of California, Riverside Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of South Carolina
 University of South Carolina Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioFX Laboratories, Inc.
BioFX Laboratories, Inc. BiotechnologyHealth Technology Develops and supplies reagents for the biomedical research market | Health Technology |
California State Polytechnic University (Pomona)
 California State Polytechnic University (Pomona) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Epic BioVentures LLC
Epic BioVentures LLC Investment ManagersFinance Epic BioVentures focuses on investments in early- to mid-stage medical device, biotechnology, diagnostic and pharmaceutical companies. The firm targets companies with: (1) modest capital requirements (2) a preferred exit strategy by acquisition or merger with a corporate partner and (3) exit timing of 3 three years, often prior to pivotal clinical trials or market launch. The Epic BioVentures I Fund invests in early to mid-stage medical technology companies with high anticipated return potential. Epic BioVentures mitigates risk through investments in a well-diversified portfolio. They seek to invest in portfolio companies with the strong potential to exit within 3 years of their investment | Finance |
